On the first day of work after the holiday, leaders visited Bai Da Nian.
Release time:
2020-08-14
festival, leaders visited the new year
. our newspaper 2# September 4 was the first day of work after the spring festival for most of the company's enterprises. the leaders of the group company paid new year greetings to the cadres and employees of overseas enterprises through the video conference system and separately visited the subordinate enterprises in Jin. On the morning of
, in the video conference room of Jianfeng Building, the management team of the Group Company extended New Year greetings to the cadres and employees of overseas enterprises such as Daye Jianfeng, Yunnan Jianfeng, Tianjin Jianfeng Natural Products, Tianjin Jianfeng Flanders and Tianjin Yikehong Biotechnology Company. Chairman Jiang Xiaomeng, on behalf of the group company, wishes all peak employees a safe and healthy year of the rooster, a beautiful family and a prosperous production and operation of all enterprises. Yunnan Jianfeng Cement Company still insisted on production during the Spring Festival. Many employees of Daye Jianfeng returned to their posts in advance to participate in the maintenance. Jiang Xiaomeng expressed special thanks to them on behalf of the company.
Jiang Xiaomeng said in his speech that in the new year, the peak is facing the challenge of improving the external market and internal management. The changes in the national economic situation and the increasingly fierce competition in the industry have all brought operational pressure to the enterprise. Therefore, all the peak people must cheer up, conscientiously organize the production and operation work, work together to do a good job in every work, seize the opportunity, and strive to achieve the development goal. After
, the leaders of the group company visited the subordinate enterprises in Jin separately to understand the implementation of the annual work plan and put forward requirements and hopes.
Jiang Xiaomeng and other leaders visited Qiubin Pharmaceutical Factory, Cable Company, Jianfeng Health Technology Company and Jinxi Pharmaceutical Factory successively. In Qiubin Factory, Jiang Xiaomeng asked to do a good job in equipment selection and dust removal for the renovation of the new workshop and put it into production through certification as soon as possible. In cable companies and health technology companies, Jiang Xiaomeng asked cable companies to control the risk of payment for goods, strengthen internal management and coordinate their work with health technology companies. Health technology companies should have new thinking and new ideas in the sales of health products to ensure product quality. Traditional Chinese medicine decoction pieces should strengthen the ability to control goods at source. Plant extraction should learn advanced technology, do a good job in superior products and reduce costs. When communicating with the management team of Jinxi Pharmaceutical Factory, Jiang Xiaomeng requested to complete the international certification of raw materials and the OEM certification of tablets as soon as possible to further improve product quality and reduce costs, go all out to cooperate with the construction of Jinderl Company, and at the same time do a good job in safety and environmental protection.
Yu Jianhong and other leaders visited Jianfeng Pharmacy, Jinhua Pharmaceutical Company, International Trading Company and other enterprises. In the peak pharmacy, Yu Jianhong visited the warehouse and other places on the spot to understand the inventory structure and financial process, and encouraged the new team of the pharmacy to further grasp the market and strive to enhance the comprehensive strength of the enterprise. In communicating with the management team of pharmaceutical companies, Yu Jianhong asked to seriously study new policies such as the "two-invoice system", do a good job in all basic work, and turn changes in the external environment and policies into opportunities for the further development of enterprises. In the international trading company, Yu Jianhong visited the bonded warehouse to understand the current logistics and warehousing business. He hoped that the management team would further clarify the direction and plan, build a high-quality service team, and make the business stronger and bigger. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page